Lack of change in microRNA expression in adult mouse liver following treatment with benzo(a)pyrene despite robust mRNA transcriptional response

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 722, Issue 2, 2011, Pages 131-139

  Yauk, Carole Lyn ^a   Jackson, Kelly ^a   Malowany, Morie ^a   Williams, Andrew ^a  

^a HEALTH CANADA   (Canada)

Author keywords

Benzo(a)pyrene; Cross platform; Gene expression; Liver; Microarray; MicroRNA; Mouse

Indexed keywords

BENZO[A]PYRENE; DIOXIN; MESSENGER RNA; MICRORNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOTOXICITY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BENZO(A)PYRENE; CIRCADIAN RHYTHM; FREEZING; GENE EXPRESSION; LIVER; MALE; MICE; MICROARRAY ANALYSIS; MICRORNAS; MUTAGENS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

MUS; RODENTIA;

EID: 79957756390     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2010.02.012     Document Type: Article

References (71)

1. Hattemer-Frey H.A., Travis C.C. Benzo-a-pyrene: environmental partitioning and human exposure. Toxicol. Ind. Health 1991, 7:141-157.
2. IARC Air Pollution, Part 1, Some Non-heterocyclic Polycyclic Aromatic Hydrocarbons and Some Related Industrial Exposures (2008) IARC, Lyon, France, in preparation.
3. Miller K.P., Ramos K.S. Impact of cellular metabolism on the biological effects of benzo[a]pyrene and related hydrocarbons. Drug Metab. Rev. 2001, 33:1-35.
4. Hankinson O. Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor. Arch. Biochem. Biophys. 2005, 433:379-386.
5. Schreck I., Chudziak D., Schneider S., Seidel A., Platt K.L., Oesch F., Weiss C. Influence of aryl hydrocarbon- (Ah) receptor and genotoxins on DNA repair gene expression and cell survival of mouse hepatoma cells. Toxicology 2009, 259:91-96.
6. Akerman G.S., Rosenzweig B.A., Domon O.E., McGarrity L.J., Blankenship L.R., Tsai C.A., Culp S.J., MacGregor J.T., Sistare F.D., Chen J.J., Morris S.M. Gene expression profiles and genetic damage in benzo(a)pyrene diol epoxide-exposed TK6 cells. Mutat. Res. 2004, 549:43-64.
7. Belitskaya-Levy I., Hajjou M., Su W.C., Yie T.A., Tchou-Wong K.M., Tang M.S., Goldberg J.D., Rom W.N. Gene profiling of normal human bronchial epithelial cells in response to asbestos and benzo(a)pyrene diol epoxide (BPDE). J. Environ. Pathol. Toxicol. Oncol. 2007, 26:281-294.
8. de Waard W.J., Aarts J.M., Peijnenburg A.A., Baykus H., Talsma E., Punt A., de Kok T.M., van Schooten F.J., Hoogenboom L.A. Gene expression profiling in Caco-2 human colon cells exposed to TCDD, benzo[a]pyrene, and natural Ah receptor agonists from cruciferous vegetables and citrus fruits. Toxicol. In vitro 2008, 22:396-410.
9. Fan Y.H., Hu Z., Li C., Wang L.E., Guo Z., Qiao Y., Zhang L., Zhang W., Mao L., Wei Q. In vitro expression levels of cell-cycle checkpoint proteins are associated with cellular DNA repair capacity in peripheral blood lymphocytes: a multivariate analysis. J. Proteome Res. 2007, 6:1560-1567.
10. Gwinn M.R., Keshava C., Olivero O.A., Humsi J.A., Poirier M.C., Weston A. Transcriptional signatures of normal human mammary epithelial cells in response to benzo[a]pyrene exposure: a comparison of three microarray platforms. OMICS 2005, 9:334-350.
11. Gwinn M.R., Weston A. Application of oligonucleotide microarray technology to toxic occupational exposures. J. Toxicol. Environ. Health A 2008, 71:315-324.
12. Hockley S.L., Mathijs K., Staal Y.C., Brewer D., Giddings I., van Delft J.H., Phillips D.H. Interlaboratory and interplatform comparison of microarray gene expression analysis of HepG2 cells exposed to benzo(a)pyrene. OMICS 2009, 13:115-125.
13. Lee C.M., Chen S.Y., Lee Y.C., Huang C.Y., Chen Y.M. Benzo[a]pyrene and glycine N-methyltransferse interactions: gene expression profiles of the liver detoxification pathway. Toxicol. Appl. Pharmacol. 2006, 214:126-135.
14. Bartosiewicz M., Penn S., Buckpitt A. Applications of gene arrays in environmental toxicology: fingerprints of gene regulation associated with cadmium chloride, benzo(a)pyrene, and trichloroethylene. Environ. Health Perspect. 2001, 109:71-74.
15. Baken K.A., Pennings J.L., Jonker M.J., Schaap M.M., de Vries A., van Steeg H., Breit T.M., van Loveren H. Overlapping gene expression profiles of model compounds provide opportunities for immunotoxicity screening. Toxicol. Appl. Pharmacol. 2008, 226:46-59.
16. De Waziers I., Garlatti M., Bouguet J., Beaune P.H., Barouki R. Insulin down-regulates cytochrome P450 2B and 2E expression at the post-transcriptional level in the rat hepatoma cell line. Mol. Pharmacol. 1995, 47:474-479.
17. Kocarek T.A., Zangar R.C., Novak R.F. Post-transcriptional regulation of rat CYP2E1 expression: role of CYP2E1 mRNA untranslated regions in control of translational efficiency and message stability. Arch. Biochem. Biophys. 2000, 376:180-190.
18. Hudder A., Novak R.F. miRNAs: effectors of environmental influences on gene expression and disease. Toxicol. Sci. 2008, 103:228-240.
19. Tsuchiya Y., Nakajima M., Takagi S., Taniya T., Yokoi T. MicroRNA regulates the expression of human cytochrome P450 1B1. Cancer Res. 2006, 66:9090-9098.
20. Ingelman-Sundberg M., Sim S.C., Gomez A., Rodriguez-Antona C. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol. Ther. 2007, 116:496-526.
21. Singh S.K., Pal Bhadra M., Girschick H.J., Bhadra U. MicroRNAs-micro in size but macro in function. FEBS J. 2008, 275:4929-4944.
22. Hutvagner G., Zamore P.D. A microRNA in a multiple-turnover RNAi enzyme complex. Science 2002, 297:2056-2060.
23. Jackson R.J., Standart N. How do microRNAs regulate gene expression?. Sci. STKE 2007, 2007:re1.
24. Kong Y.W., Cannell I.G., de Moor C.H., Hill K., Garside P.G., Hamilton T.L., Meijer H.A., Dobbyn H.C., Stoneley M., Spriggs K.A., Willis A.E., Bushell M. The mechanism of micro-RNA-mediated translation repression is determined by the promoter of the target gene. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:8866-8871.
25. Cannell I.G., Kong Y.W., Bushell M. How do microRNAs regulate gene expression?. Biochem. Soc. Trans. 2008, 36:1224-1231.
26. Guil S., Esteller M. DNA methylomes, histone codes and miRNAs: tying it all together. Int. J. Biochem. Cell Biol. 2009, 41:87-95.
27. Lynam-Lennon N., Maher S.G., Reynolds J.V. The roles of microRNA in cancer and apoptosis. Biol. Rev. Camb. Phil. Soc. 2009, 84:55-71.
28. Bueno M.J., de Castro I.P., Malumbres M. Control of cell proliferation pathways by microRNAs. Cell Cycle 2008, 7:3143-3148.
29. Carleton M., Cleary M.A., Linsley P.S. MicroRNAs and cell cycle regulation. Cell Cycle 2007, 6:2127-2132.
30. Sun B.K., Tsao H. Small RNAs in development and disease. J. Am. Acad. Dermatol. 2008, 59:725-737. quiz 738-740.
31. Xiao C., Rajewsky K. MicroRNA control in the immune system: basic principles. Cell 2009, 136:26-36.
32. Wang Y., Liang Y., Lu Q. MicroRNA epigenetic alterations: predicting biomarkers and therapeutic targets in human diseases. Clin. Genet. 2008, 74:307-315.
33. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., Golub T.R. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
34. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 2009, 10:704-714.
35. Kong W., Zhao J.J., He L., Cheng J.Q. Strategies for profiling microRNA expression. J. Cell. Physiol. 2009, 218:22-25.
36. Taylor E.L., Gant T.W. Emerging fundamental roles for non-coding RNA species in toxicology. Toxicology 2008, 246:34-39.
37. Fukushima T., Hamada Y., Yamada H., Horii I. Changes of micro-RNA expression in rat liver treated by acetaminophen or carbon tetrachloride-regulating role of micro-RNA for RNA expression. J. Toxicol. Sci. 2007, 32:401-409.
38. Wang K., Zhang S., Marzolf B., Troisch P., Brightman A., Hu Z., Hood L.E., Galas D.J. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4402-4407.
39. Pogribny I.P., Tryndyak V.P., Boyko A., Rodriguez-Juarez R., Beland F.A., Kovalchuk O. Induction of microRNAome deregulation in rat liver by long-term tamoxifen exposure. Mutat. Res. 2007, 619:30-37.
40. Zhang B., Pan X. RDX induces aberrant expression of microRNAs in mouse brain and liver. Environ. Health Perspect. 2009, 117:231-240.
41. Moffat I.D., Boutros P.C., Celius T., Linden J., Pohjanvirta R., Okey A.B. microRNAs in adult rodent liver are refractory to dioxin treatment. Toxicol. Sci. 2007, 99:470-487.
42. Lambert I.B., Singer T.M., Boucher S.E., Douglas G.R. Detailed review of transgenic rodent mutation assays. Mutat. Res. 2005, 590:1-280.
43. Kerr M.K. Design considerations for efficient and effective microarray studies. Biometrics 2003, 59:822-828.
44. Kerr M.K., Churchill G.A. Statistical design and the analysis of gene expression microarray data. Genet. Res. 2007, 89:509-514.
45. T. R.D.C. R: A language and environment for statistical computing, 2004.
46. H. Wu, M. Kerr, X. Cui, G. Churchill, Maanova: a software package for the analysis of spotted cdna microarray experiments, URL (2003) 313-341. http://dx.doi.org/10.1007/0-387-21679-0_14.
47. Cui X., Hwang J.T., Qiu J., Blades N.J., Churchill G.A. Improved statistical tests for differential gene expression by shrinking variance components estimates. Biostatistics 2005, Oxford, England, pp. 59-75.
48. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B (Methodological) 1995, 57:289-300.
49. Bolstad B.M., Irizarry R.A., Astrand M., Speed T.P. Variance and bias to compare normalization methods for high density oligonucleotide array data. Bioinformatics 2003, 19:185-193.
50. Rao Y., Lee Y., Jarjoura D., Ruppert A.S., Liu C., Hsu J.C., Hagan J.P. A comparison of normalization techniques for microRNA microarray data. Stat. Appl. Genet. Mol. Biol. 2008, 7. Epub.
51. Dennis G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., Lempicki R.A. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003, 4:P3.
52. Antonov A.V., Dietmann S., Mewes H.W. KEGG spider: interpretation of genomics data in the context of the global gene metabolic network. Genome Biol. 2008, 9:R179.
53. Sherratt P.J., Hayes J.D. Glutathione S-transferases. Enzyme Systems that Metabolise Drugs and Other Xenobiotics 2002, 319-352. Wiley & Sons, Chichester, UK. C. Ioannides (Ed.).
54. De Jong W.H., Kroese E.D., Vos J.G., Van Loveren H. Detection of immunotoxicity of benzo[a]pyrene in a subacute toxicity study after oral exposure in rats. Toxicol. Sci. 1999, 50:214-220.
55. Cullen B.R. Transcription and processing of human microRNA precursors. Mol. Cell 2004, 16:861-865.
56. Babak T., Zhang W., Morris Q., Blencowe B.J., Hughes T.R. Probing microRNAs with microarrays: tissue specificity and functional inference. RNA 2004, 10:1813-1819.
57. Lagos-Quintana M., Rauhut R., Yalcin A., Meyer J., Lendeckel W., Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 2002, 12:735-739.
58. Irizarry R.A., Warren D., Spencer F., Kim I.F., Biswal S., Frank B.C., Gabrielson E., Garcia J.G., Geoghegan J., Germino G., Griffin C., Hilmer S.C., Hoffman E., Jedlicka A.E., Kawasaki E., Martinez-Murillo F., Morsberger L., Lee H., Petersen D., Quackenbush J., Scott A., Wilson M., Yang Y., Ye S.Q., Yu W. Multiple-laboratory comparison of microarray platforms. Nat. Methods 2005, 2:345-350.
59. Shen Y.L., Jiang Y.G., Greenlee A.R., Zhou L.L., Liu L.H. MicroRNA expression profiles and miR-10a target in anti-benzo[a] pyrene-7, 8-diol-9, 10-epoxide-transformed human 16HBE cells. Biomed. Environ. Sci. 2009, 22:14-21.
60. Marsit C.J., Eddy K., Kelsey K.T. MicroRNA responses to cellular stress. Cancer Res. 2006, 66:10843-10848.
61. Cha H.J., Seong K.M., Bae S., Jung J.H., Kim C.S., Yang K.H., Jin Y.W., An S. Identification of specific microRNAs responding to low and high dose gamma-irradiation in the human lymphoblast line IM9. Oncol. Rep. 2009, 22:863-868.
62. Boorman G.A., Blackshear P.E., Parker J.S., Lobenhofer E.K., Malarkey D.E., Vallant M.K., Gerken D.K., Irwin R.D. Hepatic gene expression changes throughout the day in the Fischer rat: implications for toxicogenomic experiments. Toxicol. Sci. 2005, 86:185-193.
63. Shimba S., Watabe Y. Crosstalk between the AHR signaling pathway and circadian rhythm. Biochem. Pharmacol. 2009, 77:560-565.
64. Oishi K., Miyazaki K., Kadota K., Kikuno R., Nagase T., Atsumi G., Ohkura N., Azama T., Mesaki M., Yukimasa S., Kobayashi H., Iitaka C., Umehara T., Horikoshi M., Kudo T., Shimizu Y., Yano M., Monden M., Machida K., Matsuda J., Horie S., Todo T., Ishida N. Genome-wide expression analysis of mouse liver reveals CLOCK-regulated circadian output genes. J. Biol. Chem. 2003, 278:41519-41527.
65. Kornmann B., Preitner N., Rifat D., Fleury-Olela F., Schibler U. Analysis of circadian liver gene expression by ADDER, a highly sensitive method for the display of differentially expressed mRNAs. Nucleic Acids Res. 2001, 29:E51-E151.
66. Gachon F., Olela F.F., Schaad O., Descombes P., Schibler U. The circadian PAR-domain basic leucine zipper transcription factors DBP, TEF, and HLF modulate basal and inducible xenobiotic detoxification. Cell Metab. 2006, 4:25-36.
67. Okada K., Yano M., Doki Y., Azama T., Iwanaga H., Miki H., Nakayama M., Miyata H., Takiguchi S., Fujiwara Y., Yasuda T., Ishida N., Monden M. Injection of LPS causes transient suppression of biological clock genes in rats. J. Surg. Res. 2008, 145:5-12.
68. Currie R.A., Bombail V., Oliver J.D., Moore D.J., Lim F.L., Gwilliam V., Kimber I., Chipman K., Moggs J.G., Orphanides G. Gene ontology mapping as an unbiased method for identifying molecular pathways and processes affected by toxicant exposure: application to acute effects caused by the rodent non-genotoxic carcinogen diethylhexylphthalate. Toxicol. Sci. 2005, 86:453-469.
69. Matsuo T., Yamaguchi S., Mitsui S., Emi A., Shimoda F., Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science 2003, 302:255-259.
70. Sato S., Shirakawa H., Tomita S., Ohsaki Y., Haketa K., Tooi O., Santo N., Tohkin M., Furukawa Y., Gonzalez F.J., Komai M. Low-dose dioxins alter gene expression related to cholesterol biosynthesis, lipogenesis, and glucose metabolism through the aryl hydrocarbon receptor-mediated pathway in mouse liver. Toxicol. Appl. Pharmacol. 2008, 229:10-19.
71. Garrett R.W., Gasiewicz T.A. The aryl hydrocarbon receptor agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin alters the circadian rhythms, quiescence, and expression of clock genes in murine hematopoietic stem and progenitor cells. Mol. Pharmacol. 2006, 69:2076-2083.